These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 16951233)
21. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]. Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953 [TBL] [Abstract][Full Text] [Related]
22. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346 [TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study. Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342 [TBL] [Abstract][Full Text] [Related]
24. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth. Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671 [TBL] [Abstract][Full Text] [Related]
25. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor. Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800 [TBL] [Abstract][Full Text] [Related]
26. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Schwarzenbach H; Müller V; Stahmann N; Pantel K Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935 [TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder. Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332 [TBL] [Abstract][Full Text] [Related]
28. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients]. Zhang H; Li Z; Chen M; Zhang G; Xu K Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406 [TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance. Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732 [TBL] [Abstract][Full Text] [Related]
30. High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Shao J; Li Y; Wu Q; Liang X; Yu X; Huang L; Hou J; Huang X; Ernberg I; Hu LF; Zeng Y Chin Med J (Engl); 2002 Apr; 115(4):571-5. PubMed ID: 12133301 [TBL] [Abstract][Full Text] [Related]
31. Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence. Rawnaq T; Schwarzenbach H; Schurr PG; Freise K; Brandl S; Izbicki JR; Kaifi JT J Surg Res; 2011 Jul; 169(1):31-5. PubMed ID: 20417938 [TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma. Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235 [TBL] [Abstract][Full Text] [Related]
33. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients. Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609 [TBL] [Abstract][Full Text] [Related]
34. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. Koo SH; Jeong TE; Kang J; Kwon KC; Park JW; Noh SM Cancer Genet Cytogenet; 2004 Aug; 153(1):26-31. PubMed ID: 15325090 [TBL] [Abstract][Full Text] [Related]
36. Molecular evidence supporting field effect in urothelial carcinogenesis. Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427 [TBL] [Abstract][Full Text] [Related]
37. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms. Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578 [TBL] [Abstract][Full Text] [Related]
39. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease. Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419 [TBL] [Abstract][Full Text] [Related]
40. [Identification of some macrosatillite sites of chromosome 19 in primary gastric carcinoma with loss of heterozygosity]. Jiang M; Xu L; Zhao Y; Fang HH; Chen ZH; Gao Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):455-9. PubMed ID: 17611325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]